Table 4.
Gender-dependent adherence to general cardio-preventive criteria
|
Criteria |
Adherence (%) [95% Cl] |
|
|---|---|---|
| |
Men |
Women |
| n=123 | n=102 | |
|
High level of adherence to general cardio-preventive measures |
|
|
| • Patient with apparent contraindication/intolerance to aspirin therapy is prescribed clopidogrel 75 mg |
100 |
100 |
| • Prescribing of angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin II receptor blockers (ARBs) post myocardial infarction |
100 |
100 |
| • Prescribing of beta-blocker in post myocardial infarction patients or in patients with coronary heart disease |
68.8 [56.7-80.9] |
88.0* [76.1-97.9] |
| • Prescribing of ACE-I/ARB in patients with microalbuminuria/proteinuria |
76.1 [63.8-88.4] |
75.7 [61.9-89.5] |
|
Intermediate level of adherence to general cardio-preventive measures |
|
|
| • Patient aged ≥40 years is prescribed a statin when pretreatment serum cholesterol was ≥200 mg/dl |
67.4 [57.7-77.2] |
60.9 [50.7-71.2] |
|
Low level of adherence to general cardio-preventive measures |
|
|
| • Patient who is described a statin has achieved a triglyceride level of 350 mg/dl and LDL level of 80 mg/dl |
40.3 [28.1-52.5] |
19.6** [4.0-24.8] |
| • Patient aged ≥50 years is prescribed aspirin |
53.4 [42.0-64.9] |
37.1* [25.8-48.5] |
| • Patients aged <50 years with cardiovascular risk factors is prescribed aspirin |
5.9 [0–17.1] |
0 |
| • Patient who continues to smoke has been offered smoking cessation advice which involves structured behavioural support plus nicotine replacement therapy or bupropion/varenicline | 0 | 0 |
* P < 0.05, ** P < 0.01.